Skip to main content

Surgical Management of Bone Disease

  • Chapter
  • First Online:
Myeloma Bone Disease

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Minimally invasive surgery plays an increasingly important role in the management of bone disease in patients with myeloma. The spine is the most common site of bone involvement in myeloma, and minimally invasive vertebral augmentation techniques have been developed which are safe and effective in relieving pain related to vertebral compression fractures in patients with myeloma. Vertebroplasty relieves pain and stabilizes the fractured vertebral body by injecting bone cement percutaneously into the cancellous area, however more recently its role in pain management has been questioned in two double blinded randomized clinical trials. Kyphoplasty is a similar technique, but uses an inflatable tamp to create a uniform cavity in which the bone cement is injected. Compared with vertebroplasty, kyphoplasty is associated with less cement leakage and has the added advantage of restoring vertebral height, which relieves stress on adjacent vertebral bodies and may reduce the risk of additional fractures. Continued improvements in myeloma therapy and the development of these minimally invasive techniques have increased the potential for more patients to be eligible for vertebral augmentation, which may have a favorable impact on pain, disability, quality of life, and even reduction in mortality. Vertebral augmentation is the procedure of choice for myeloma patients with severe pain related to vertebral compression fractures and may play a role in relieving pain and preventing impending fractures in patients with other conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Durie BG. New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals. Clin Lymphoma Myeloma. 2005;6:181–190.

    Article  CAS  PubMed  Google Scholar 

  2. Durie BG, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the scientific advisors of the international myeloma foundation. Hematol J. 2003;4:379–398.

    Article  PubMed  Google Scholar 

  3. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975;50:29–40.

    CAS  PubMed  Google Scholar 

  4. Cotten A, Dewatre F, Cortet B, et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology. 1996;200:525–530.

    CAS  PubMed  Google Scholar 

  5. Hussein MA, Vrionis FD, Allison R, et al. The role of vertebral augmentation in multiple myeloma: international myeloma working group consensus statement. Leukemia. 2008;22:1479–1484.

    Article  CAS  PubMed  Google Scholar 

  6. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215–1220.

    Article  CAS  PubMed  Google Scholar 

  7. Djulbegovic B, Wheatley K, Ross J, et al. Cochrane Database Syst Rev. 2002;2: CD003188.

    Google Scholar 

  8. Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology bisphosphonates expert panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20: 3719–3736.

    Article  PubMed  Google Scholar 

  9. Berenson JR, Lichtenstein A, Porter L, et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. J Clin Oncol. 1998;16:593–602.

    CAS  PubMed  Google Scholar 

  10. Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med. 1996;334:488–493.

    Article  CAS  PubMed  Google Scholar 

  11. McCloskey EV, MacLennan IC, Drayson MT, Chapman C, Dunn J, Kanis JA. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC working party of leukaemia in adults. Br J Haematol. 1998;100:317–325.

    Article  CAS  PubMed  Google Scholar 

  12. McCloskey EV, Dunn JA, Kanis JA, MacLennan IC, Drayson MT. Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol. 2001;113:1035–1043.

    Article  CAS  PubMed  Google Scholar 

  13. Gertz BJ, Holland SD, Kline WF, et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58:288–298.

    Article  CAS  PubMed  Google Scholar 

  14. Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 2001;7:377–387.

    CAS  PubMed  Google Scholar 

  15. Zeifang F, Zahlten-Hinguranage A, Goldschmidt H, Cremer F, Bernd L, Sabo D. Long-term survival after surgical intervention for bone disease in multiple myeloma. Ann Oncol. 2005;16:222–227.

    Article  CAS  PubMed  Google Scholar 

  16. Chang SA, Lee SS, Ueng SW, Yuan LJ, Shih CH. Surgical treatment for pathological long bone fracture in patients with multiple myeloma: a retrospective analysis of 22 cases. Chang Gung Med J. 2001;24:300–306.

    CAS  PubMed  Google Scholar 

  17. Harrington KD. Orthopedic surgical management of skeletal complications of malignancy. Cancer. 1997;80(8 Suppl):1614–1627.

    Article  CAS  PubMed  Google Scholar 

  18. Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop Relat Res. 1997;341:192–205.

    Article  PubMed  Google Scholar 

  19. Colyer RA. Surgical stabilization of pathological neoplastic fractures. Curr Probl Cancer. 1986;10:117–168.

    Article  CAS  PubMed  Google Scholar 

  20. Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18:459–469.

    Article  PubMed  Google Scholar 

  21. Sapkota BH, Hirsch AE, Yoo AJ, et al. Treatment of metastatic carcinoma to the hip with CT-guided percutaneous acetabuloplasty: report of four cases. J Vasc Interv Radiol. 2009;20:548–552.

    Article  PubMed  Google Scholar 

  22. Lieberman I, Reinhardt MK. Vertebroplasty and kyphoplasty for osteolytic vertebral collapse. Clin Orthop Relat Res. 2003;415(Suppl):S176–S186.

    Article  PubMed  Google Scholar 

  23. Shepherd S. Radiotherapy and the management of metastatic bone pain. Clin Radiol. 1988;39:547–550.

    Article  CAS  PubMed  Google Scholar 

  24. Yeh HS, Berenson JR. Treatment for myeloma bone disease. Clin Cancer Res. 2006;12(20 Part 2):6279s–6284s.

    Article  CAS  PubMed  Google Scholar 

  25. Dudeney S, Lieberman IH, Reinhardt MK, Hussein M. Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol. 2002;20:2382–2387.

    Article  CAS  PubMed  Google Scholar 

  26. Galibert P, Deramond H, Rosat P, Le Gars D. [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty]. Neurochirurgie. 1987;33:166–168 (French).

    CAS  PubMed  Google Scholar 

  27. Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am. 1998;36:533–546.

    Article  CAS  PubMed  Google Scholar 

  28. Deramond H, Wright NT, Belkoff SM. Temperature elevation caused by bone cement polymerization during vertebroplasty. Bone. 1999;25(2 Suppl):17S–21S.

    Article  CAS  PubMed  Google Scholar 

  29. Jensen ME, Evans AJ, Mathis JM, Kallmes DF, Cloft HJ, Dion JE. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol. 1997;18:1897–1904.

    CAS  PubMed  Google Scholar 

  30. Kayanja M, Evans K, Milks R, Lieberman IH. The mechanics of polymethylmethacrylate augmentation. Clin Orthop Relat Res. 2006;443:124–130.

    Article  PubMed  Google Scholar 

  31. Kayanja MM, Schlenk R, Togawa D, Ferrara L, Lieberman I. The biomechanics of 1, 2, and 3 levels of vertebral augmentation with polymethylmethacrylate in multilevel spinal segments. Spine. 2006;31:769–774.

    Article  PubMed  Google Scholar 

  32. Pateder DB, Khanna AJ, Lieberman IH. Vertebroplasty and kyphoplasty for the management of osteoporotic vertebral compression fractures. Orthop Clin North Am. 2007;38: 409–418.

    Article  PubMed  Google Scholar 

  33. Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine. 2000;25:923–928.

    Article  CAS  PubMed  Google Scholar 

  34. Keller TS, Kosmopoulos V, Lieberman IH. Vertebroplasty and kyphoplasty affect vertebral motion segment stiffness and stress distributions: a microstructural finite-element study. Spine. 2005;30:1258–1265.

    Article  PubMed  Google Scholar 

  35. Cortet B, Cotten A, Boutry N, et al. Percutaneous vertebroplasty in patients with osteolytic metastases or multiple myeloma. Rev Rhum Engl Ed. 1997;64:177–183.

    CAS  PubMed  Google Scholar 

  36. Cotten A, Boutry N, Cortet B, et al. Percutaneous vertebroplasty: state of the art. Radiographics. 1998;18:311–320.

    CAS  PubMed  Google Scholar 

  37. Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557–568.

    Google Scholar 

  38. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569–579.

    Google Scholar 

  39. Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373:1016–1024.

    Article  PubMed  Google Scholar 

  40. Vrionis FD, Hamm A, Stanton N, Sullivan M, Obadia M, Miguel RV. Kyphoplasty for tumor-associated spinal fractures. Tech Reg Anesth Pain Manag. 2005;9:35–39.

    Article  Google Scholar 

  41. Khanna AJ, Reinhardt MK, Togawa D, Lieberman IH. Functional outcomes of kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures. Osteoporos Int. 2006;17:817–826.

    Article  CAS  PubMed  Google Scholar 

  42. Shedid D, Togawa D, Lieberman IH. Kyphoplasty: vertebral augmentation for compression fractures. Clin Geriatr Med. 2006;22:535–544.

    Article  PubMed  Google Scholar 

  43. Harrop JS, Prpa B, Reinhardt MK, Lieberman I. Primary and secondary osteoporosis’ incidence of subsequent vertebral compression fractures after kyphoplasty. Spine. 2004;29:2120–2125.

    Article  PubMed  Google Scholar 

  44. Lieberman IH, Dudeney S, Reinhardt MK, Bell G. Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures. Spine. 2001;26:1631–1638.

    Article  CAS  PubMed  Google Scholar 

  45. Pflugmacher R, Agarwal A, Kandziora F, K-Klostermann C. Balloon kyphoplasty combined with posterior instrumentation for the treatment of burst fractures of the spine – 1-year results. J Orthop Trauma. 2009;23:126–131.

    Article  PubMed  Google Scholar 

  46. Phillips FM, Wetzel FT, Lieberman I, Campbell-Hupp M. An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty. Spine. 2002;27:2173–2179.

    Article  PubMed  Google Scholar 

  47. Pflugmacher R, Kandziora F, Schoeder RJ, Melcher I, Haas NP, Klostermann CK. Percutaneous balloon kyphoplasty in the treatment of pathological vertebral body fracture and deformity in multiple myeloma: a one-year follow-up. Acta Radiol. 2006;47:369–376.

    Article  CAS  PubMed  Google Scholar 

  48. Köse KC, Cebesoy O, Akan B, Altinel L, Dinçer D, Yazar T. Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients. J Natl Med Assoc. 2006;98:1654–1658.

    PubMed  Google Scholar 

  49. Lane JM, Hong R, Koob J, et al. Kyphoplasty enhances function and structural alignment in multiple myeloma. Clin Orthop Relat Res. 2004;426:49–53.

    Article  PubMed  Google Scholar 

  50. Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature. Spine J. 2008;8:488–497.

    Article  PubMed  Google Scholar 

  51. Khanna AJ, Neubauer P, Togawa D, Kay Reinhardt M, Lieberman IH. Kyphoplasty and vertebroplasty for the treatment of spinal metastases. Support Cancer Ther. 2005;3:21–25.

    Article  PubMed  Google Scholar 

  52. Lieberman I, Goins M, An H, Phillips F. Summary statement: kyphoplasty and nucleus pulposus prosthesis. Spine J. 2005;5(6 Suppl):325S.

    Article  PubMed  Google Scholar 

  53. Lieberman IH, Togawa D, Kayanja MM. Vertebroplasty and kyphoplasty: filler materials. Spin J. 2005;5(6 Suppl):305S–316S.

    Article  Google Scholar 

  54. Bostrom MP, Lane JM.. Future directions. Augmentation of osteoporotic vertebral bodies. Spine. 1997;22(24 Suppl):38S–42S.

    Article  CAS  PubMed  Google Scholar 

  55. Togawa D, Bauer TW, Lieberman IH, Takikawa S. Histologic evaluation of human vertebral bodies after vertebral augmentation with polymethyl methylacrylate. Spine. 2003;28:1521–1527.

    Article  PubMed  Google Scholar 

  56. Togawa D, Lieberman IH, Bauer TW, Reinhardt MK, Kayanja MM. Histological evaluation of biopsies obtained from vertebral compression fractures: unsuspected myeloma and osteomalacia. Spine. 2005;30:781–786.

    Article  PubMed  Google Scholar 

  57. Togawa D, Kovacic JJ, Bauer TW, Reinhardt MK, Brodke DS, Lieberman IH. Radiographic and histologic findings of vertebral augmentation using polymethylacrylate in the primate spine: percutaneous vertebroplasty versus kyphoplasty. Spine. 2006;31:E4–E10.

    Article  PubMed  Google Scholar 

  58. Mroz TE, Yamashita T, Davros WJ, Lieberman IH. Radiation exposure to the surgeon and the patient during kyphoplasty. J Spinal Disord Tech. 2008;21:96–100.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamad A. Hussein .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hussein, M.A. (2010). Surgical Management of Bone Disease. In: Roodman, G. (eds) Myeloma Bone Disease. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60761-554-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-554-5_5

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-553-8

  • Online ISBN: 978-1-60761-554-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics